Organizations Filed Purposes:
THE MISSION OF IGC IS TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES BY RIGOROUSLY DEVELOPING AND APPLYING POST-GENOME SCIENCE TO ADVANCES IN HUMAN HEALTH.
WORK TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES.
ISPECIMEN - ISPECIMEN ADDRESSES A CRITICAL CHALLENGEM CONNECTING LIFE SCIENCE RESEARCHERS WHO NEED HUMAN BIOSPECIMENS WITH THE BILLIONS OF SPECIMENS AVAILABLE IN HEALTHCARE ORGANIZATIONS WORLDWIDE. ISPECIMEN'S GROUND-BREAKING MARKETPLACE SOLVES THIS PROBLEM, REINVENTING THE BIOSPECIMEN PROCUREMENT PROCESS TO ACCELERATE MEDICAL RECOVERY.
VIOMICS - DIAGNOSTIC AND BIOMARKER RESEARCH WITH A FOCUS ON LUNG CANCER.
PARADIGM DIAGNOSTICS - PARADIGM'S RESEARCH BRINGS CUTTING EDGE DIAGNOSTICS AND BIOMARKER DRIVEN CLINICAL TRIALS TO THE BENEFIT OF CANCER PATIENTS. PARADIGM ATTEMPTS TO DEVELOP POTENTIAL THERAPIES BASED ON SPECIFIC CHARACTERIZATION OF THE PATIENT'S TUMOR, PERSONALIZING EACH PATIENT'S COURSE OF TREATMENT.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Vanesa Romero | CFO | 10 | $28,550 |
| Erin Curley | BOARD MEMBER | 10 | $10,000 |
| Robert Armknecht Jr | BOARD MEMBER | 0.5 | $10,000 |
| Shelby Scharbach | BOARD OBSERVER - NONVOTING | 5 | $0 |
| Richard Mallery Esq | CHAIRMAN OF THE BOARD | 0.5 | $0 |
| David Mallery | PRESIDENT & CEO | 10 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202003219349311805_public.xml